Chinese Journal of Tissue Engineering Research ›› 2021, Vol. 25 ›› Issue (25): 3962-3969.doi: 10.12307/2021.005
Previous Articles Next Articles
Sun Jianwei1, Yang Xinming2, Zhang Ying2
|  QU S, MENG HL, LIANG ZG, et al. Comparison of Short-Course Radiotherapy Versus Long-Course Radiotherapy for Treatment of Metastatic Spinal Cord Compression: A Systematic Review and Meta-Analysis. Medicine (Baltimore). 2015;94(43):e1843.
 LI Z, CHEN L, LI B, et al. Efficacy and Safety of Surgical Interventions for Treating Multilevel Cervical Spondylotic Myelopathy via Anterior Approach: A Network Meta-Analysis. Pain Physician. 2019;22(4): E275-E286.
 MA JK, WEST CR, MARTIN GINIS KA. The Effects of a Patient and Provider Co-Developed, Behavioral Physical Activity Intervention on Physical Activity, Psychosocial Predictors, and Fitness in Individuals with Spinal Cord Injury: A Randomized Controlled Trial. Sports Med. 2019;49(7):1117-1131.
 SHENDE P, SUBEDI M. Pathophysiology, mechanisms and applications of mesenchymal stem cells for the treatment of spinal cord injury. Biomed Pharmacother. 2017;91:693-706.
 YAGURA K, OHTAKI H, TSUMURAYA T, et al. The enhancement of CCL2 and CCL5 by human bone marrow-derived mesenchymal stem/stromal cells might contribute to inflammatory suppression and axonal extension after spinal cord injury. PLoS One. 2020;15(3):e0230080.
 LIU W, WANG Y, GONG F, et al. Exosomes Derived from Bone Mesenchymal Stem Cells Repair Traumatic Spinal Cord Injury by Suppressing the Activation of A1 Neurotoxic Reactive Astrocytes. J Neurotrauma. 2019;36(3):469-484.
 SATTI HS, WAHEED A, AHMED P, et al. Autologous mesenchymal stromal cell transplantation for spinal cord injury: A Phase I pilot study. Cytotherapy. 2016;18(4):518-522.
 KORKMAZ K, GEDIK HS, BUDAK AB, et al. Effect of Montelukast on Spinal Cord Ischemia- Reperfusion Injury. Turk Neurosurg. 2015;25(5): 757-765.
 GELOSA P, BONFANTI E, CASTIGLIONI L, et al. Improvement of fiber connectivity and functional recovery after stroke by montelukast, an available and safe anti-asthmatic drug. Pharmacol Res. 2019;142: 223-236.
 CAVUS G, ALTAS M, ARAS M, et al. Effects of montelukast and methylprednisolone on experimental spinal cord injury in rats. Eur Rev Med Pharmacol Sci. 2014;18(12):1770-1777.
 COURTINE G, SOFRONIEW MV. Spinal cord repair: advances in biology and technology. Nat Med. 2019;25(6):898-908.
 ORR MB, GENSEL JC. Spinal Cord Injury Scarring and Inflammation: Therapies Targeting Glial and Inflammatory Responses. Neurotherapeutics. 2018;15(3):541-553.
 GAUDET AD, FONKEN LK. Glial Cells Shape Pathology and Repair After Spinal Cord Injury. Neurotherapeutics. 2018;15(3):554-577.
 LIN L, LIN H, BAI S, et al. Bone marrow mesenchymal stem cells (BMSCs) improved functional recovery of spinal cord injury partly by promoting axonal regeneration. Neurochem Int. 2018;115:80-84.
 LI D, ZHANG P, YAO X, et al. Exosomes Derived From miR-133b-Modified Mesenchymal Stem Cells Promote Recovery After Spinal Cord Injury. Front Neurosci. 2018;12:845.
 LI C, JIAO G, WU W, et al. Exosomes from Bone Marrow Mesenchymal Stem Cells Inhibit Neuronal Apoptosis and Promote Motor Function Recovery via the Wnt/β-catenin Signaling Pathway. Cell Transplant. 2019;28(11):1373-1383.
 SHAO A, TU S, LU J, et al. Crosstalk between stem cell and spinal cord injury: pathophysiology and treatment strategies. Stem Cell Res Ther. 2019;10(1):238.
 HA XQ, YANG B, HOU HJ, et al. Protective effect of rhodioloside and bone marrow mesenchymal stem cells infected with HIF-1-expressing adenovirus on acute spinal cord injury. Neural Regen Res. 2020;15(4):690-696.
 MANSOUR RM, AHMED MAE, EL-SAHAR AE, et al. Montelukast attenuates rotenone-induced microglial activation/p38 MAPK expression in rats: Possible role of its antioxidant, anti-inflammatory and antiapoptotic effects. Toxicol Appl Pharmacol. 2018;358:76-85.
 DAVID S, ZARRUK JG, GHASEMLOU N. Inflammatory pathways in spinal cord injury. Int Rev Neurobiol. 2012;106:127-152.
 HE Z, ZANG H, ZHU L, et al. An anti-inflammatory peptide and brain-derived neurotrophic factor-modified hyaluronan-methylcellulose hydrogel promotes nerve regeneration in rats with spinal cord injury. Int J Nanomedicine. 2019;14:721-732.
 LI Z, WU F, XU D, et al. Inhibition of TREM1 reduces inflammation and oxidative stress after spinal cord injury (SCI) associated with HO-1 expressions. Biomed Pharmacother. 2019;109:2014-2021.
 CASHA S, RICE T, STIRLING DP, et al. Cerebrospinal Fluid Biomarkers in Human Spinal Cord Injury from a Phase II Minocycline Trial. J Neurotrauma. 2018;35(16):1918-1928.
 WANG C, SHI D, SONG X, et al. Calpain inhibitor attenuates ER stress-induced apoptosis in injured spinal cord after bone mesenchymal stem cells transplantation. Neurochem Int. 2016;97:15-25.
 LI C, CHEN X, QIAO S, et al. Effects of Wharton’s jelly cells of the human umbilical cord on acute spinal cord injury in rats, and expression of interleukin-1β and nerve growth factor in spinal cord tissues. Artif Cells Nanomed Biotechnol. 2016;44(5):1254-1258.
 BRADBURY EJ, BURNSIDE ER. Moving beyond the glial scar for spinal cord repair. Nat Commun. 2019;10(1):3879.
 HUANG X, KIM JM, KONG TH, et al. GM-CSF inhibits glial scar formation and shows long-term protective effect after spinal cord injury. J Neurol Sci. 2009;277(1-2):87-97.
 DU XJ, CHEN YX, ZHENG ZC, et al. Neural stem cell transplantation inhibits glial cell proliferation and P2X receptor-mediated neuropathic pain in spinal cord injury rats. Neural Regen Res. 2019;14(5):876-885.
 LI Z, LIU F, HE X, et al. Exosomes derived from mesenchymal stem cells attenuate inflammation and demyelination of the central nervous system in EAE rats by regulating the polarization of microglia. Int Immunopharmacol. 2019;67:268-280.
 OKADA S, HARA M, KOBAYAKAWA K, et al. Astrocyte reactivity and astrogliosis after spinal cord injury. Neurosci Res. 2018;126:39-43.
 JAIMES Y, NAALDIJK Y, WENK K, et al. Mesenchymal Stem Cell-Derived Microvesicles Modulate Lipopolysaccharides-Induced Inflammatory Responses to Microglia Cells. Stem Cells. 2017;35(3):812-823.
 GAO J, SUN Z, XIAO Z, et al. Dexmedetomidine modulates neuroinflammation and improves outcome via alpha2-adrenergic receptor signaling after rat spinal cord injury. Br J Anaesth. 2019; 123(6):827-838.
 KEEFE KM, SHEIKH IS, SMITH GM. Targeting Neurotrophins to Specific Populations of Neurons: NGF, BDNF, and NT-3 and Their Relevance for Treatment of Spinal Cord Injury. Int J Mol Sci. 2017;18(3):548.
 GAO K, SHEN Z, YUAN Y, et al. Simvastatin inhibits neural cell apoptosis and promotes locomotor recovery via activation of Wnt/β-catenin signaling pathway after spinal cord injury. J Neurochem. 2016;138(1):139-149.
 FU XM, WANG Y, FU WL, et al. The Combination of Adipose-derived Schwann-like Cells and Acellular Nerve Allografts Promotes Sciatic Nerve Regeneration and Repair through the JAK2/STAT3 Signaling Pathway in Rats. Neuroscience. 2019;422:134-145.
 HERRMANN JE, IMURA T, SONG B, et al. STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury. J Neurosci. 2008;28(28):7231-7243.
 TAMURA M, NAKAMURA M, OGAWA Y, et al. Targeted expression of anti-apoptotic protein p35 in oligodendrocytes reduces delayed demyelination and functional impairment after spinal cord injury. Glia. 2005;51(4):312-321.
 GENOVESE T, ROSSI A, MAZZON E, et al. Effects of zileuton and montelukast in mouse experimental spinal cord injury. Br J Pharmacol. 2008;153(3):568-582.
 ZHOU C, SHI X, HUANG H, et al. Montelukast attenuates neuropathic pain through inhibiting p38 mitogen-activated protein kinase and nuclear factor-kappa B in a rat model of chronic constriction injury. Anesth Analg. 2014;118(5):1090-1096.
 VAQUERO J, ZURITA M, RICO MA, et al. Intrathecal administration of autologous mesenchymal stromal cells for spinal cord injury: Safety and efficacy of the 100/3 guideline. Cytotherapy. 2018;20(6):806-819.
|||Pu Rui, Chen Ziyang, Yuan Lingyan. Characteristics and effects of exosomes from different cell sources in cardioprotection [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(在线): 1-.|
|||Min Youjiang, Yao Haihua, Sun Jie, Zhou Xuan, Yu Hang, Sun Qianpu, Hong Ensi. Effect of “three-tong acupuncture” on brain function of patients with spinal cord injury based on magnetic resonance technology [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(在线): 1-8.|
|||Lin Qingfan, Xie Yixin, Chen Wanqing, Ye Zhenzhong, Chen Youfang. Human placenta-derived mesenchymal stem cell conditioned medium can upregulate BeWo cell viability and zonula occludens expression under hypoxia [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(在线): 4970-4975.|
|||Jiang Hongying, Zhu Liang, Yu Xi, Huang Jing, Xiang Xiaona, Lan Zhengyan, He Hongchen. Effect of platelet-rich plasma on pressure ulcers after spinal cord injury [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(8): 1149-1153.|
|||Zhang Xiumei, Zhai Yunkai, Zhao Jie, Zhao Meng. Research hotspots of organoid models in recent 10 years: a search in domestic and foreign databases [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(8): 1249-1255.|
|||Wang Xianyao, Guan Yalin, Liu Zhongshan. Strategies for improving the therapeutic efficacy of mesenchymal stem cells in the treatment of nonhealing wounds [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(7): 1081-1087.|
|||Wan Ran, Shi Xu, Liu Jingsong, Wang Yansong. Research progress in the treatment of spinal cord injury with mesenchymal stem cell secretome [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(7): 1088-1095.|
|||Liao Chengcheng, An Jiaxing, Tan Zhangxue, Wang Qian, Liu Jianguo. Therapeutic target and application prospects of oral squamous cell carcinoma stem cells [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(7): 1096-1103.|
|||Xie Wenjia, Xia Tianjiao, Zhou Qingyun, Liu Yujia, Gu Xiaoping. Role of microglia-mediated neuronal injury in neurodegenerative diseases [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(7): 1109-1115.|
|||Li Shanshan, Guo Xiaoxiao, You Ran, Yang Xiufen, Zhao Lu, Chen Xi, Wang Yanling. Photoreceptor cell replacement therapy for retinal degeneration diseases [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(7): 1116-1121.|
|||Jiao Hui, Zhang Yining, Song Yuqing, Lin Yu, Wang Xiuli. Advances in research and application of breast cancer organoids [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(7): 1122-1128.|
|||Wang Shiqi, Zhang Jinsheng. Effects of Chinese medicine on proliferation, differentiation and aging of bone marrow mesenchymal stem cells regulating ischemia-hypoxia microenvironment [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(7): 1129-1134.|
|||Zeng Yanhua, Hao Yanlei. In vitro culture and purification of Schwann cells: a systematic review [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(7): 1135-1141.|
|||Kong Desheng, He Jingjing, Feng Baofeng, Guo Ruiyun, Asiamah Ernest Amponsah, Lü Fei, Zhang Shuhan, Zhang Xiaolin, Ma Jun, Cui Huixian. Efficacy of mesenchymal stem cells in the spinal cord injury of large animal models: a meta-analysis [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(7): 1142-1148.|
|||Hou Jingying, Yu Menglei, Guo Tianzhu, Long Huibao, Wu Hao. Hypoxia preconditioning promotes bone marrow mesenchymal stem cells survival and vascularization through the activation of HIF-1α/MALAT1/VEGFA pathway [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(7): 985-990.|